Home » Topics » Regulatory » Patents

Patents
RSS

New use claimed for olanzapine

Nov. 26, 1996

Melatonin receptor ligands described by ADIR

Nov. 26, 1996

New retinoid-like compounds from BMS

Nov. 26, 1996

New NMDA antagonists described by Zeneca

Nov. 26, 1996

Asta Medica reports new PDE IV and PDE V inhibitors

Nov. 26, 1996

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

Sandoz claims MAbs against Lewis group antigens for therapeutic use

Nov. 25, 1996

More antiobesity proteins reported by Lilly

Nov. 25, 1996

Maxi-K channel modulators from Bristol-Myers Squibb

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...